Evidence map›Paper›PMID 38109523›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

A distinct human cell type expressing MHCII and RORγt with dual characteristics of dendritic cells and type 3 innate lymphoid cells.

Alina Ulezko Antonova, Silvia Lonardi, Matilde Monti, Francesco Missale, Changxu Fan, Matthew L Coates, Mattia Bugatti, Natalia Jaeger, Patrick Fernandes Rodrigues, Simone Brioschi and 15 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. RORγtScience immunology · 2026
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. RORγt eTACs mediate oral tolerance and Treg induction.The Journal of experimental medicine · 2025
    Article
  16. Review
  17. Article
  18. The dual nature of TFEBS letters · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 10 institutions in 4 countries.

Alina Ulezko Antonova *Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.
Silvia Lonardi *Department of Molecular and Translational Medicine, University of Brescia, Brescia 25125, Italy.
Matilde MontiDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25125, Italy.
Francesco MissaleDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25125, Italy.
Changxu FanDepartment of Genetics, Washington University School of Medicine, Saint Louis, MO 63110.
Matthew L CoatesMolecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QH, United Kingdom.
Mattia BugattiDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25125, Italy.
Natalia JaegerDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.
Patrick Fernandes RodriguesDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.
Simone BrioschiDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.
Tihana TrsanDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.
José L FachiDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.
Khai M NguyenDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.
Ryan M NunleyWashington University Orthopedics, Barnes Jewish Hospital, Saint Louis, MO 63110.
Daniele MorattoDepartment of Lab Diagnostics, Azienda Socio Sanitaria Territoriale Spedali Civili di Brescia, Brescia 25100, Italy.
Stefania ZiniDepartment of Molecular and Translational Medicine, University of Brescia, Brescia 25125, Italy.
Lingjia KongImmunology Program, Broad Institute of Massachussets Institute of Technology and Harvard, Cambridge, MA 02142.
Jacques DeguineCenter for Computational and Integrative Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.ORCID 0000-0001-9218-3040
Mark E PeeplesInfectious Diseases Institute, The Ohio State University, Columbus, OH 43210.ORCID 0000-0002-4582-317X
Ramnik J XavierImmunology Program, Broad Institute of Massachussets Institute of Technology and Harvard, Cambridge, MA 02142.
Menna R ClatworthyMolecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QH, United Kingdom.
Ting WangDepartment of Genetics, Washington University School of Medicine, Saint Louis, MO 63110.
Marina CellaDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.ORCID 0000-0003-1230-1313
William VermiDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.ORCID 0000-0002-2291-2997
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.ORCID 0000-0001-5222-4987
Washington University in St. Louis · USUniversity of Brescia · ITBroad Institute · USAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITBarnes-Jewish Hospital · USHarvard University · USNational Health Service · GBNationwide Children's Hospital · USThe Netherlands Cancer Institute · NLUniversity of Cambridge · GB

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Jeffrey Wade Brown · 2000 to 2026
$30.8M
Technology Development Project - Increasing the complexity of ex vivo human airway models for studying immune response to viral infectionU19AI142733 · NIAID · JACKSON LABORATORY · PI Anna Karolina Palucka · 2019 to 2026
$23.1M
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITYR01AI134035 · NIAID · WASHINGTON UNIVERSITY · PI MARCO COLONNA, Eugene M Oltz · 2018 to 2026
$4.8M
Mucosal Immune Defense Mechanisms of the Urinary BladderR01DK132327 · NIDDK · WASHINGTON UNIVERSITY · PI MARCO COLONNA, SCOTT J. HULTGREN · 2023 to 2026
$2.5M
MICROBIOTA-DEPENDENT CONTROL OF CLOSTRIDIUM DIFFICILE: THE ROLE OF ACETATE AND IL-22 BINDING PROTEINR01DK126969 · NIDDK · WASHINGTON UNIVERSITY · PI COLONNA, MARCO · 2021 to 2024
$1.6M
Plasticity of Innate Lymphoid Cells: Mechanisms and Biological ImpactR01DK124699 · NIDDK · WASHINGTON UNIVERSITY · PI COLONNA, MARCO · 2020 to 2023
$1.4M
NCATS NIH HHS UL1 TR002345NCI NIH HHS P30 CA091842NIAID NIH HHS R01 AI134035NIAID NIH HHS U19 AI142733NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30 DK052574NIDDK NIH HHS R01 DK124699NIDDK NIH HHS R01 DK126969NIDDK NIH HHS R01 DK132327
6 · The paper itself

Abstract

Recent studies have characterized various mouse antigen-presenting cells (APCs) expressing the lymphoid-lineage transcription factor RORγt (Retinoid-related orphan receptor gamma t), which exhibit distinct phenotypic features and are implicated in the induction of peripheral regulatory T cells (Tregs) and immune tolerance to microbiota and self-antigens. These APCs encompass Janus cells and Thetis cell subsets, some of which express the AutoImmune REgulator (AIRE). RORγt

Indexed as

Immunity, InnateLymphocytesAnimalsDendritic CellsHumansInflammationMiceNuclear Receptor Subfamily 1, Group F, Member 3Nuclear Receptor Subfamily 1, Group F, Member 3antigen presentationdendritic cellshumaninnate lymphoid cellsretinoid-related orphan receptor gamma t

Identifiers

PMID38109523
PMCPMC10756205
OpenAlexW4389879773

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.